Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT06196905
Brief Summary:
To explore the efficacy, safety, pharmacokinetics and mechanism of action of MT-2990 in patients with AAV.
Detailed Description:
Target sample size is 5\~10 subjects administered MT-2990
Study:
NCT06196905
Study Brief:
Protocol Section:
NCT06196905